GlycoMimetics Inc. appointed Patricia Andrews to its board of directors.
Andrews is CEO and director of privately held Boston Biomedical Inc.
Discover more about S&P Global’s offerings
GlycoMimetics appoints director
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy
GlycoMimetics Inc. appointed Patricia Andrews to its board of directors.
Andrews is CEO and director of privately held Boston Biomedical Inc.